SEC Form 4 · accession 0001209191-16-153708
Everyday Health, Inc. · EVDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael du Toit
Officer — President
Period of report
Dec 3, 2016
Accepted (ET)
Dec 6, 2016 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358483
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 3, 2016 | U | 54,964 | $10.50 | D | 124,000 | D | |
| Common Stock | Dec 5, 2016 | A | 20,000 | $0.00 | A | 144,000 | D | |
| Common StockF3 | Dec 5, 2016 | D | 82,000 | $10.50 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposed of pursuant to a cash tender offer conducted in accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated October 21, 2016, among the Issuer, Ziff Davis, LLC, a Delaware limited liability company (the "Parent"), Project Echo Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") and j2 Global, Inc. in exchange for cash consideration of $10.50 per share, without interest and less any applicable tax withholding. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger").
- F2Represents the acquisition of 20,000 shares underlying performance-based restricted stock units accelerated pursuant to the terms of the Reporting Person's employment agreement with the Issuer in connection with the Merger. An additional 20,000 shares underlying unvested performance-based restricted stock units were cancelled and extinguished for no consideration pursuant to the terms of the Merger Agreement.
- F3Pursuant to the terms of the Reporting Person's employment agreement with the Issuer, the vesting of restricted stock units for an aggregate of 82,000 shares (including 20,000 shares underlying performance-based restricted stock units, as described in footnote (2) above) was accelerated in connection with the Merger. Pursuant to the terms of the Merger Agreement, these accelerated restricted stock units were cancelled and converted into the right to receive cash consideration of $10.50 per share (without interest and less any applicable tax withholding). An additional 82,000 shares underlying unvested restricted stock units (including 20,000 shares underlying unvested performance-based restricted stock units, as described in footnote (2) above) were cancelled and extinguished for no consideration pursuant to the terms of the Merger Agreement.